Premium Nahrungsergänzungsmittel | artgerecht

Artemisia annua Cancer – Effects & Research

Artemisia annua is a medicinal plant whose active compound artemisinin is being studied in cancer research. Early studies suggest potential anti-tumor properties.

Regular tips about health Regular tips about health

Things worth knowing about "Artemisia annua Cancer"

Artemisia annua is a medicinal plant whose active compound artemisinin is being studied in cancer research. Early studies suggest potential anti-tumor properties.

Artemisia annua and Cancer – A Medicinal Plant in Oncology Research

Artemisia annua, commonly known as sweet wormwood or annual wormwood, is a medicinal plant from the daisy family (Asteraceae). It has been used for thousands of years in traditional Chinese medicine. Its key active compound, artemisinin, is best known as an antimalarial agent, but is increasingly being investigated in modern oncology for its potential anti-tumor properties.

Mechanism of Action Against Cancer Cells

Artemisinin and its derivatives (e.g., dihydroartemisinin, artesunate, artemether) act on cancer cells through multiple mechanisms:

Reactive oxygen species (ROS): Artemisinin reacts with iron (Fe²⁺), which is present in particularly high concentrations in cancer cells, generating free radicals that damage or destroy tumor cells.
Induction of apoptosis: The compound can trigger programmed cell death (apoptosis) in tumor cells without affecting healthy cells to the same extent.
Inhibition of cell proliferation: Artemisinin derivatives can slow or block the uncontrolled division of cancer cells.
Anti-angiogenic effects: The substance can inhibit the formation of new blood vessels within tumors (angiogenesis), thereby cutting off the blood supply to the tumor.
Immunomodulation: There is evidence suggesting that artemisinin may support the immune system in its defense against cancer.

Scientific Evidence and Research Status

Research into Artemisia annua and cancer is still at an early stage. Many studies have been conducted in cell cultures (in vitro) or animal models (in vivo). However, initial clinical studies in humans are showing promising results, particularly for:

Breast cancer
Colorectal cancer
Leukemia
Lung cancer
Prostate cancer

Nevertheless, large-scale, randomized clinical trials (Phase III studies) confirming clear efficacy as a cancer treatment in humans are still lacking. Artemisinin and its derivatives are therefore currently regarded as complementary treatment approaches, not as standard oncological therapy.

Application and Dosage

Within complementary oncology, Artemisia annua is used in various forms:

Plant extracts and capsules with standardized artemisinin content
Pure artemisinin or semi-synthetic derivatives such as artesunate (primarily in clinical research settings)
Tea preparations made from dried Artemisia annua leaves (with lower artemisinin content)

The optimal dosage for potential cancer applications has not yet been scientifically established. Dosages should only be determined in consultation with a physician or oncologist.

Safety and Side Effects

Artemisinin and its derivatives are generally well tolerated when used at therapeutic doses. Possible side effects include:

Gastrointestinal complaints (nausea, diarrhea)
Cardiac arrhythmias at high doses
Neurological symptoms at very high doses (dizziness, tinnitus)
Interactions with certain cancer medications and other drugs

Important note: Artemisia annua should under no circumstances be used as a replacement for conventional cancer therapies such as chemotherapy, radiation therapy, or surgery. Its use should always be discussed with and supervised by a treating oncologist.

References

Efferth T. – Artemisinin: A versatile weapon in the fight against malaria and cancer. In: Frontiers in Oncology, 2017; 7:297. PubMed PMID: 29234606.
Krishna S., Bustamante L., Haynes R. K., Staines H. M. – Artemisinins: their growing importance in medicine. Trends in Pharmacological Sciences, 2008; 29(10):520-527.
World Health Organization (WHO) – Artemisinin-based combination therapies and cancer research context. WHO Technical Reports, Geneva.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.